Semnur Pharmaceuticals, Inc. (SMNR)
0.55
0.00 (0.00%)
USD |
OTCM |
Aug 31, 16:00
Semnur Pharmaceuticals Enterprise Value : 149.63M for Aug. 31, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 31, 2026 | 149.63M |
| August 28, 2026 | 149.63M |
| August 27, 2026 | 156.53M |
| August 26, 2026 | 165.74M |
| August 25, 2026 | 163.44M |
| August 24, 2026 | 165.74M |
| August 21, 2026 | 177.28M |
| August 20, 2026 | 177.25M |
| August 19, 2026 | 211.67M |
| August 18, 2026 | 207.18M |
| August 17, 2026 | 175.18M |
| August 14, 2026 | 216.39M |
| August 13, 2026 | 207.16M |
| August 12, 2026 | 173.82M |
| August 11, 2026 | 195.67M |
| August 10, 2026 | 195.67M |
| August 07, 2026 | 214.09M |
| August 06, 2026 | 218.69M |
| August 05, 2026 | 197.97M |
| August 04, 2026 | 223.29M |
| August 03, 2026 | 228.36M |
| July 31, 2026 | 218.69M |
| July 30, 2026 | 207.18M |
| July 29, 2026 | 204.88M |
| July 28, 2026 | 173.80M |
| Date | Value |
|---|---|
| July 27, 2026 | 168.04M |
| July 24, 2026 | 179.56M |
| July 23, 2026 | 172.65M |
| July 22, 2026 | 193.37M |
| July 21, 2026 | 170.39M |
| July 20, 2026 | 209.48M |
| July 17, 2026 | 188.76M |
| July 16, 2026 | 186.46M |
| July 15, 2026 | 187.61M |
| July 14, 2026 | 223.29M |
| July 13, 2026 | 197.97M |
| July 10, 2026 | 179.56M |
| July 09, 2026 | 196.25M |
| July 08, 2026 | 172.65M |
| July 07, 2026 | 216.39M |
| July 06, 2026 | 207.18M |
| July 02, 2026 | 195.67M |
| July 01, 2026 | 184.16M |
| June 30, 2026 | 138.12M |
| June 29, 2026 | 249.79M |
| June 26, 2026 | 157.71M |
| June 25, 2026 | 272.81M |
| June 24, 2026 | 176.12M |
| June 23, 2026 | 134.68M |
| June 22, 2026 | 108.03M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Scilex Holding Co. | 141.89M |
| ANI Pharmaceuticals, Inc. | 1.917B |
| Corcept Therapeutics, Inc. | 11.93B |
| Veru, Inc. | 24.63M |
| Johnson & Johnson | 668.51B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.347M |
| Total Expenses (Quarterly) | 4.347M |
| EPS Diluted (Quarterly) | -0.0189 |
| Earnings Yield | -149.5% |
| Normalized Earnings Yield | -149.47 |